Universidad del Desarrollo: Clinical Trials

29 trials sponsored by Universidad del Desarrollo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 9 unknown, 6 recruiting, 2 not yet recruiting. 15 Not applicable, 5 Phase 4, 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable15Completed 6, Recruiting 5, Unknown 3, Not yet recruiting 1
Phase 45Completed 3, Unknown 2
Phase 23Unknown 3
Phase 31Active not recruiting 1

Follow Universidad del Desarrollo: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Volumetric Efficacy of Alveolar Ridge Preservation
Spontaneous Healing, d-PTFE Membrane, Leukocyte- and Platelet-Rich Fibrin (L-PRF) - Alveolar Ridge Preservation, Tooth Loss
Not applicableRecruitingUniversidad del Desarrollo702026-09-152026-09-10
mHealth Intervention to Prevent Postpartum Depression and Anxiety in Chilean Women (WWWT)
What Were We Thinking (WWWT) mHealth Intervention - Postpartum Depression (PPD), Postpartum Anxiety
Not applicableNot yet recruitingUniversidad del Desarrollo2202026-05-012026-05-14
Efficacy of a New Composition (BU002) for Debridement of Chronic Cutaneous Ulcers
BU002, Polyhexanide 0.1% and betaine 0.1% gel - Ulcer Venous, Ulcer Foot
Not applicableRecruitingUniversidad del Desarrollo802025-10-012026-05-26
Decreasing the Stigma of Mental Illness Among Health Science Students Through a Mentoring Program
Mentoring program, Control (placebo) group - Social Stigma
Not applicableUnknownUniversidad del Desarrollo1022025-08-012024-09-19
Evaluation of a Novel Self-Sampling Earwax Tool for Chronic Disease Biomarkers [TREARS STUDIES II]
Metabolic Syndrome, Diabetes
Not yet recruitingTrears2582025-07-012025-04-17
The Study Evaluates the Effect of an Interactive Projector as a Distraction for Children During Anesthetic Induction. The Primary Objective is to Reduce Perioperative Anxiety, Measured With the Modified Yale Preoperative Anxiety Scale (mYPAS).
Custom projector-based video game intervention (BERT; Stanford Chariot Program, Palo Alto, CA), Standard Parent-Present Induction (PPI) - Anxiety, Anxiety After Surgery
Not applicableRecruitingClinica Alemana de Santiago702025-07-012025-11-17
Effectiveness of Enhanced Dialectical Behavior Therapy Skills Training Group for Borderline Personality Disorder
Enhanced Dialectical Behavior Therapy Skills Training, Dialectical Behavior Therapy, Treatment as Usual (TAU) - Borderline Personality Disorder (BPD), Dialectical Behavior Therapy
Not applicableRecruitingHospital Dr Sotero del Rio3602025-06-182026-10-15
A Pilot Study of Trauma-Focused Cognitive-Behavioral Therapy for Treatment of Post-traumatic Stress in Adults.
Trauma-Focused Cognitive Behavioral Therapy for complex presentation (TF-CBT-CP) - Post Traumatic Stress Disorder, Complex Post-Traumatic Stress Disorder
Not applicableRecruitingUniversity of Talca132024-10-222026-02-03
Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation
Photobiomodulation, Usual care - Hematologic Cancer
Not applicableUnknownUniversidad del Desarrollo302024-06-102024-07-11
Workplace Intervention to Reduce Sitting Time: a Randomized Clinical Trial.
Computer prompt "Stand up for your Health®" - Sedentary Behavior, Office Workers
Not applicableCompletedUniversidad del Desarrollo1062023-09-162025-05-15
Effects of Virtual Reality Software on Levels of Stigma Towards People With Mental Illness.
Virtual Reality Software Intervention - Social Stigma, Virtual Reality
Not applicableCompletedUniversidad del Desarrollo1222022-06-012022-12-07
Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy
Atorvastatin, Standard Care - Neurocognitive Impairment, Mild
Phase 3Active not recruitingThe George Institute1902022-03-102025-04-10
Clinical Trial Through Combined tACS Therapy in Patients With Mild Cognitive Impairment
Combined tACS and Cognitive Training Program, Traditional Cognitive Training Program - Mild Cognitive Impairment
Phase 2UnknownUniversidad del Desarrollo622022-01-262023-09-01
Evaluation of the EEG Connectivity Using Predominant Dexmedetomidine as Anesthetic in Fragile Brains
Comparison MoCA test and EEG connectivity pre, intra and postoperative between groups P vs D-P - Aging Problems
UnknownUniversidad del Desarrollo242022-01-022022-06-21
Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster
Placebo, Inactivated vaccine booster, mRNA vaccine booster - Covid19
Phase 2UnknownUniversidad del Desarrollo5342021-07-082021-08-05
Feasibility of M-health Version of "What Were We Thinking" Intervention to Promote Maternal Postpartum Mental Health
m-health version of WWWT intervention, Treatment as usual - Depression, Postpartum, Anxiety Disorders and Symptoms
Not applicableCompletedUniversidad del Desarrollo1282021-04-032026-05-12
Copper Use as Protection Against Antimicrobial Resistance in the ICU
Copper-based surfaces plus copper-enriched linen - Healthcare Associated Infection
Not applicableCompletedUniversidad del Desarrollo1682020-11-022023-01-19
Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic
Intensive care unit stay during the COVID-19 pandemic - Covid19, Critical Care
CompletedUniversidad del Desarrollo2522020-10-202024-07-12
Effectiveness of the Use of Desensitizing Dentifrices Based on Nanocrystals of Hydroxyapatite / 5% Potassium Nitrate / 1450ppm Sodium Monofluorophosphate and Potassium Nitrate 5% / 1426ppm Sodium Floride in the Treatment of Dentine Hypersensitivity. Test Randomized Clinical
DEENSIBILIZING TOOTHPASTE BASED ON NANOCRISTALS OF HYDROXIAPATITA / 5% POTASSIC NITRATE / SODIUM MONOFluORPHOSPHATE 1450 PARTS PER MILLION, 5% POTASSIC NITRATE / SODIUM FLUORIDE 1426 PARTS PER MILLION TOOTHPASTE - Hypersensitivity Dentin
Not applicableUnknownUniversidad del Desarrollo322020-04-102019-11-07
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
DiGeorge Syndrome, 22q11.2 Deletion Syndrome
RecruitingAlbert Einstein College of Medicine10002016-07-012026-07-29

Showing 20 of 29. Sign in to see all of them.

Conditions studied

COVID-19 (3)  ·  Anxiety Disorders (2)  ·  Depression, Postpartum (2)  ·  Obesity (2)  ·  Social Stigma (2)  ·  Borderline Personality Disorder (1)  ·  Bronchiolitis, Viral (1)  ·  Chronic Disease (1)  ·  Cognitive Dysfunction (1)  ·  Cross Infection (1)  ·  Dentin Sensitivity (1)  ·  DiGeorge Syndrome (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Disease Progression (1)

Interventions

Standard of Care (2)  ·  Therapeutics (2)  ·  Atorvastatin (1)  ·  BNT162 Vaccine (1)  ·  Dialectical Behavior Therapy (1)  ·  Electrocardiography (1)  ·  Leukocyte Count (1)  ·  Low-Level Light Therapy (1)  ·  Population Groups (1)  ·  Progesterone (1)  ·  Propofol (1)  ·  sinovac COVID-19 vaccine (1)

Countries

Chile (22)  ·  Australia (1)  ·  United States (1)

Top investigators

Bernice E. Morrow, PhD (1)  ·  Cinara Sacomori, Ph.D. (1)  ·  Claudio M Miranda, dds (1)  ·  Claudio Mizon, MD (1)  ·  Craig Anderson, MD (1)  ·  Dusan M Marinkovic, DDS (1)  ·  Jaime E Leppe Zamora, PhD© (1)  ·  Jose M Munita, MD (1)  ·  Manuel Espinoza, B.Sc. M.D Msc. Ph.D. (1)  ·  Pablo Billeke, PhD (1)  ·  Pablo Lavados, MD (1)

Results publications

PMID 29401079, PMID 29661412, PMID 34497087, PMID 36300324, PMID 37010196, PMID 37695822, PMID 37972091, PMID 38395980, PMID 39461860, PMID 40228860, PMID 41360439, PMID 42399564

NIH funding

R01HL084410 (1), R01HL157157 (1)